Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Genet. 1996 Dec;12(12):510-5.

Anti-gene therapy: the use of ribozymes to inhibit gene function.

Author information

1
Ribozyme Pharmaceuticals, Inc, Bouldar, CO 80301, USA.

Abstract

The ability of certain enzymatic RNA molecules, or ribozymes, to site-specifically cleave other RNA molecules opens new vistas in gene therapy. Ribozymes can be designed to target specifically a particular mRNA and inhibit protein expression, permitting 'anti-gene' therapy. Here, we describe the progress towards developing ribozymes for use in gene therapy applications. Significant advances have been made in understanding ribozyme transcription unit design and the first clinical tests of ribozyme safety in humans are soon to be initiated.

PMID:
9257533
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center